Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Joshua Milner, MD, to Lead Pediatric Allergy, Immunology, and Rheumatology at Columbia University Irving Medical Center and NewYork-Presbyterian Morgan Stanley Children's Hospital

Renowned immunologist Joshua Milner, MD, named chief of pediatric allergy, immunology, and rheumatology at Columbia University Irving Medical Center and NewYork-Presbyterian Morgan Stanley Children's Hospital


News provided by

Columbia University Irving Medical Center

Oct 04, 2019, 10:15 ET

Share this article

Share toX

Share this article

Share toX

NEW YORK, Oct. 4, 2019 /PRNewswire/ -- Joshua Milner, MD, an internationally renowned physician-scientist from the National Institutes of Health (NIH) whose research has uncovered the genetic underpinnings of allergic diseases in children, has been named Chief of the Division of Allergy, Immunology, and Rheumatology in Pediatrics at Columbia University Vagelos College of Physicians and Surgeons and professor of pediatrics in the Institute for Genomic Medicine at Columbia University Irving Medical Center. Dr. Milner will also serve as chief of the allergy, immunology, and rheumatology services at NewYork-Presbyterian Morgan Stanley Children's Hospital.

Continue Reading
Joshua Milner, MD, named chief, pediatric allergy, immunology, & rheumatology at Columbia University Irving Medical Center and NewYork-Presbyterian Morgan Stanley Children's Hospital (photo credit: CUIMC)
Joshua Milner, MD, named chief, pediatric allergy, immunology, & rheumatology at Columbia University Irving Medical Center and NewYork-Presbyterian Morgan Stanley Children's Hospital (photo credit: CUIMC)

He will assume both roles starting on November 1, 2019.

"As a pediatric immunologist, I firmly believe that immunology touches most disciplines in medicine, and may well be the most important underlying element connecting so many diseases affecting children," said Jordan S. Orange, MD, PhD, the Reuben S. Carpentier Professor and Chair of the Department of Pediatrics at Columbia University Vagelos College of Physicians and Surgeons and Pediatrician-in-Chief at NewYork-Presbyterian Morgan Stanley Children's Hospital. "A highly respected leader in the field of pediatric immunology, Dr. Milner will strengthen our clinical, research, and educational programs throughout the Department of Pediatrics, our children's hospital, and our entire clinical and academic network. It signifies our commitment to providing the highest quality of care while leading in innovation as Columbia and NewYork-Presbyterian have throughout our history." 

"We are delighted to welcome Dr. Milner to NewYork-Presbyterian Morgan Stanley Children's Hospital as the leader of our allergy, immunology, and rheumatology services," said Craig Albanese, MD, senior vice president and chief operating officer of NewYork-Presbyterian Morgan Stanley Children's Hospital. "Dr. Milner is a gifted clinician and renowned researcher. His expertise in pediatric immunologic diseases will help to expand our services and bolster our mission to provide the most innovative, compassionate care to our patients."

Dr. Milner's work has probed some of the basic immunological mechanisms driving allergic diseases and other types of immune dysfunction. His research led to the discovery of primary atopic disorders—a group of genetic disorders that cause immune-system dysfunction and predispose individuals to develop allergic conditions, ranging from severe hives to eczema to food allergies.

One such disorder, PLAID, triggers an allergic reaction to cold temperatures. Another, PGM3 deficiency, leads to several types of severe allergies and infections, beginning in childhood.

"Dr. Milner's research has brought some of the most rare and lethal pediatric immunologic diseases into the spotlight," said Fred Modell, co-founder of the Jeffrey Modell Foundation, which has established a JMF diagnostic and research center at Columbia University Irving Medical Center that will be led by Dr. Milner. "His new appointment will transform Columbia and NewYork-Presbyterian into a regional destination for the diagnosis and treatment of children with rare immunologic diseases," added Vicki Modell, co-founder of the foundation.

"Allergic diseases are extremely common in children, but only recently have we begun to appreciate the immunologic and genetic complexity of even the mildest of these diseases," said Dr. Milner. "I welcome the opportunity to join Columbia University and NewYork-Presbyterian, where a unique ecosystem of researchers, physicians, and a diverse patient population offers the opportunity to continue this important research and develop new therapeutic approaches for children with allergic diseases."

"I am also excited about conducting this work in a department led by Dr. Orange, a renowned pediatric allergist and immunologist who appreciates the importance of using immunology to better understand allergic, immunodeficiency, and rheumatologic diseases," Dr. Milner continued.

In addition to continuing his research, Dr. Milner will see pediatric patients and perform clinical training and mentorship to students, residents, fellows, and junior faculty. His division will also be home to the allergy/immunology fellowship at Columbia University Vagelos College of Physicians and Surgeons, which was previously administered by the Department of Medicine.

Previously, Dr. Milner led a team of researchers investigating the genetics and pathogenesis of allergies in the Laboratory of Allergic Diseases at the National Institute of Allergy and Infectious Disease (NIAID) of the NIH, where he joined as a tenure-track investigator in 2009. In 2013, he was appointed senior investigator in the NIAID Laboratory of Allergic Diseases and in 2017, Dr. Milner was named chief of the laboratory, where he directed several clinical and research programs in pediatric allergy, including an esteemed fellowship program.

Dr. Milner earned a bachelor's degree in biology from the Massachusetts Institute of Technology and a medical degree from the Albert Einstein College of Medicine, with special distinction in immunology. He completed a residency in pediatrics at Children's National Medical Center in Washington, DC, followed by a fellowship in allergy and immunology at NIAID with the late William E. Paul.

Dr. Milner is board-certified in allergy and immunology. He has been elected to the American Society for Clinical Investigation, the Association of American Physicians, and the Henry Kunkel Society. He has received numerous awards, including two NIH Director's Awards, two NIAID Merit Awards, the 2015 Phadia Allergy Research Forum Award, the 2017 Gale and Ira Drukier Prize in children's health research, and the Society for Pediatric Research's 2019 E. Mead Johnson Award. He has published more than 100 papers and serves on the editorial boards of numerous scientific journals.

Columbia University Irving Medical Center

Columbia University Irving Medical Center provides international leadership in basic, preclinical, and clinical research; medical and health sciences education; and patient care. The medical center trains future leaders and includes the dedicated work of many physicians, scientists, public health professionals, dentists, and nurses at the Vagelos College of Physicians and Surgeons, the Mailman School of Public Health, the College of Dental Medicine, the School of Nursing, the biomedical departments of the Graduate School of Arts and Sciences, and allied research centers and institutions. Columbia University Irving Medical Center is home to the largest medical research enterprise in New York City and State and one of the largest faculty medical practices in the Northeast. For more information, visit cuimc.columbia.edu or columbiadoctors.org.

Columbia Pediatrics

Columbia Pediatrics is among the top ranked pediatrics departments in the nation with more than $20 million per year in research funding from the National Institutes of Health, and it is the only department of pediatrics in New York ranked among the top 25 in the US by US News & World Report. Located at the NewYork-Presbyterian Morgan Stanley Children's Hospital/Columbia University Irving Medical Center campus in Washington Heights, the department is home to more than 250 clinicians and researchers. Throughout the department's long and distinguished history faculty members have made seminal contributions to advances in diagnosing and treating the full spectrum of pediatric diseases and disorders. Find out more at www.pediatrics.columbia.edu

NewYork-Presbyterian

NewYork-Presbyterian is one of the nation's most comprehensive, integrated academic healthcare systems, encompassing 10 hospital campuses across the Greater New York area, more than 200 primary and specialty care clinics and medical groups, and an array of telemedicine services. 

A leader in medical education, NewYork-Presbyterian Hospital is the only academic medical center in the nation affiliated with two world-class medical schools, Weill Cornell Medicine and Columbia University Vagelos College of Physicians and Surgeons. This collaboration means patients have access to the country's leading physicians, the full range of medical specialties, latest innovations in care, and research that is developing cures and saving lives. 

Ranked the #5 hospital in the nation and #1 in New York in U.S. News & World Report's "Best Hospitals" survey, NewYork-Presbyterian Hospital is also recognized as among the best in the nation in every pediatric specialty evaluated in the U.S. News "Best Children's Hospitals" survey. Founded nearly 250 years ago, NewYork-Presbyterian Hospital has a long legacy of medical breakthroughs and innovation, from the invention of the Pap test to the first successful pediatric heart transplant, to pioneering the groundbreaking heart valve replacement procedure called TAVR. 

NewYork-Presbyterian's 47,000 employees and affiliated physicians are dedicated to providing the highest quality, most compassionate care to New Yorkers and patients from across the country and around the world. NewYork-Presbyterian hospitals are not for profit and provide more than $1 billion in benefits every year to the community, including medical care, school-based health clinics and support for more than 300 community programs and activities. 

For more information, visit www.nyp.org  and find us on Facebook, Twitter, Instagram, and YouTube.

SOURCE Columbia University Irving Medical Center

Related Links

http://www.cumc.columbia.edu

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.